Multidrug resistant bacterial infection in liver transplant recipients: A Deterrent and obstacle
Pakistan Journal of Medical Sciences · 29.07.2026 · 42 (8) · 2078-2087
DOI: 10.12669/pjms.42.8.15347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 29.07.2026. Verfasst von Nazish Misbah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nazish Misbah, FCPS (Medicine), FCPS (Infectious Disease), Dow University Hospital, Dow University of Health Sciences, Karachi Pakistan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
To determine the microbiological spectrum of multi-drug resistant (MDR) bacterial infections within the first 30 days post-living donor liver transplantation (LDLT) and identify the associated risk factors contributing to their emergence. Methodology: This retrospective cohort study reviewed the medical records of patients who underwent LDLT from January 2020 to December 2024 at the Liver Transplant and Hepatopancreatobiliary Surgery Unit of Dow University Hospital, Karachi. Patients were categorized into MDR and no-MDR groups based on culture-confirmed MDR bacterial infection with clinical features of sepsis. Types of MDR bacterial infections were noted. Baseline, pre-transplant, intraoperative, and post-transplant variables were recorded. Pearson Chi-square test, Mann-Whitney U test, and univariate and multivariate logistic regression analyses were performed for statistical inference.
Results
Of 151 LDLT recipients, 75 (49.7%) developed MDR bacterial infections within 30 days. Among these, gram negative MDR organisms were predominated, with carbapenem-resistant Enterobacteriaceae (21.2%) and carbapenem-resistant Acinetobacter baumannii (20.5%) most frequent, followed by vancomycin-resistant Enterococci (13.2%). On univariate analysis, MDR infection was associated with pre-transplant ICU admission, renal dysfunction, prolonged postoperative ICU stay, mechanical ventilation >48 h, hemodialysis and/or sustained low-efficiency dialysis (SLED), postoperative complications, longer invasive device duration, prolonged hospital stay, central line-associated blood stream infection (CLABSI), and intra-abdominal infections. On multivariate analysis, only CLABSI [Wald χ²=17.696 (OR 0.021; 95% CI: 0.003–0.127; p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nazish Misbah, FCPS (Medicine), FCPS (Infectious Disease), Dow University Hospital, Dow University of Health Sciences, Karachi Pakistan.
- Jahanzaib Haider, MCPS, MHPE, FCPS, Fellowship in Liver Transplant and HPB Surgery Liver Transplant and Hepatopancreatobiliary Surgery Unit, Dow University Hospital, Dow University of Health Sciences, Karachi Pakistan.
- Muhammad Hassan, FCPS, Fellowship in Liver Transplant and HPB Surgery Liver Transplant and Hepatopancreatobiliary Surgery Unit, Dow University Hospital, Dow University of Health Sciences, Karachi Pakistan.
- Mehreen Fatima, FCPS (Medicine), FCPS (Infectious Disease) Department of Infectious Disease, Dow University Hospital, Dow University of Health Sciences, Karachi Pakistan.
Zitieren
APA
Misbah, N., Haider, J., Hassan, M., & Fatima, M. (2026). Multidrug resistant bacterial infection in liver transplant recipients: A Deterrent and obstacle. Pakistan Journal of Medical Sciences, 42(8), 2078-2087. https://doi.org/10.12669/pjms.42.8.15347
Vancouver
Misbah N, Haider J, Hassan M, Fatima M. Multidrug resistant bacterial infection in liver transplant recipients: A Deterrent and obstacle. Pakistan Journal of Medical Sciences. 2026;42(8):2078-2087. doi:10.12669/pjms.42.8.15347
BibTeX
@article{Misbah2026,
author = {Misbah, Nazish and Haider, Jahanzaib and Hassan, Muhammad and Fatima, Mehreen},
title = {Multidrug resistant bacterial infection in liver transplant recipients: A Deterrent and obstacle},
journal = {Pakistan Journal of Medical Sciences},
year = {2026},
volume = {42},
number = {8},
pages = {2078--2087},
doi = {10.12669/pjms.42.8.15347}
}
EUVIMED